Cost-Effectiveness of Subthalmic Nucleus Deep Brain Stimulation for the Treatment of Advanced Parkinson Disease in Hong Kong: A Prospective Study
Publication in policy or professional journal

Times Cited
Web of Science16WOS source URL (as at 23/09/2021) Click here for the latest count
Altmetrics Information

Other information
AbstractBACKGROUND: Deep brain stimulation (DBS) is an effective but costly treatment for patients with advanced Parkinson disease (PD). This study examined the cost-effectiveness of DBS in relation to its improved effectiveness to help funding decision makers decide whether the treatment should be adopted. The incremental cost-effective ratio (ICER) per quality-adjusted life year has been benchmarked as being between US$50,000 and US$100,000 by US agencies, whereas it is less than (sic)30,000 per quality-adjusted life year in Europe.
All Author(s) ListZhu XL, Chan DTM, Lau CKY, Poon WS, Mok VCT, Chan AYY, Wong LKS, Yeung JHM, Leung MCM, Tang VYH, Wong RKM, Yeung C
Journal nameWorld Neurosurgery
Volume Number82
Issue Number6
LanguagesEnglish-United Kingdom
KeywordsCost-effectiveness; Deep brain stimulation; EQ5D; Parkinson disease; PD39; QALY; Quality of Life; Subthalamic nucleus; UPDRS
Web of Science Subject CategoriesClinical Neurology; Neurosciences & Neurology; Surgery

Last updated on 2021-24-09 at 00:16